NP Life Sciences Health Industry Group Inc. Financing Cash Flow
NP Life Sciences Health Industry Group Inc. (ACAT) reported Financing Cash Flow of $22.36 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-16.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-04-16
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $0.00.
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $0.00.
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for the quarter ending 2019-12-31 was $0.00.
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for the quarter ending 2019-09-30 was $0.00.
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for fiscal 2023 was $22.36K.
- NP Life Sciences Health Industry Group Inc. net cash provided by (used in) financing activities for fiscal 2019 was $364.43K.
| Period end | Net Cash Provided by (Used in) Financing Activities 0 month | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-16 | $0.00 derived: sum of 2 quarters · filed 2024-04-16 | $22.36K 10-K · filed 2024-04-16 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $22.36K 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $22.36K 10-Q · filed 2023-08-14 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-04-15 | $0.00 derived: sum of 2 quarters · filed 2021-04-15 | $260.13K derived: sum of 3 quarters · filed 2021-04-15 | $364.43K 10-K · filed 2021-04-15 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | $260.13K derived: sum of 2 quarters · filed 2020-11-16 | $364.43K 10-Q · filed 2020-11-16 | ||
| 2019-06-30 | $260.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $364.43K 10-Q · filed 2020-08-14 | |||
| 2019-03-31 | $104.30K 10-Q · filed 2020-05-15 | ||||
| 2018-12-31 | $200.00 10-K · filed 2020-03-30 |